Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 25 March 2027
- Last conf. stmt
- 11 March 2026
Complement Therapeutics Limited
- Incorporated
- 12 March 2020 (6 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Robbie Woodman
- Accounts type
- Small
- Region
- Greater London
- Address
- 4th FloorTranslation And Innovation Hub 84 Wood LaneWhite CityLondonW12 0BZ
Officers 3 active
Officer details are public data from the Companies House register.
Woodman, Robbie
Director · Appointed 4 May 2023
British
Born October 1977 (49)
British
Born March 1965 (61)
Director · Appointed 15 May 2021
British
Born May 1968 (58)
Officer history (11 former)
4 May 2023
Appointed Woodman, Robbie as Director
24 March 2023
24 March 2023
Resigned Axon, Steven Robert as Director
24 March 2023
Resigned Van Wezel, Edward as Director
24 March 2023
24 March 2023
Resigned Hristodorov, Dmitrij as Director
24 March 2023
Resigned Bishop, Paul Nicholas, Professor as Director
24 March 2023
Resigned Mulder, Geert-Jan as Director
24 March 2023
Resigned Dos Santos Couto, Daniela Andreia as Director
1 June 2022
Appointed Axon, Steven Robert as Director
26 April 2022
Resigned Klement, Maximilian as Director
26 April 2022
Appointed Van Wezel, Edward as Director
16 February 2022
Appointed Hristodorov, Dmitrij as Director
16 February 2022
Appointed Mulder, Geert-Jan as Director
20 January 2022
15 May 2021
14 May 2021
26 March 2021
Appointed Dos Santos Couto, Daniela Andreia as Director
26 March 2021
Appointed Klement, Maximilian as Director
26 March 2021
26 March 2021
Resigned Clark, Simon, Professor as Director
26 March 2021
Resigned Unwin, Richard, Dr as Director
12 March 2020
Appointed Clark, Simon, Professor as Director
12 March 2020
Appointed Unwin, Richard, Dr as Director
12 March 2020
Appointed Bishop, Paul Nicholas, Professor as Director
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Financials
Figures from 2021 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £1,315,903
- Debt Ratio
- 9%
- Current Ratio
- 7.3x
Balance sheet detail
| 2021 | |
|---|---|
| Fixed Assets | £492,070 |
| Current Assets | £954,722 |
| Creditors (< 1 year) | £130,889 |
| Creditors (> 1 year) | £0 |
| Net Current Assets | £823,833 |
| Net Assets | £1,315,903 |
| Shareholder Funds | £1,315,903 |
Filings
Filing history not loaded yet. See it on Companies House
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →